BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 20714351)

  • 1. Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent Salmonella infection.
    Johanns TM; Ertelt JM; Rowe JH; Way SS
    PLoS Pathog; 2010 Aug; 6(8):e1001043. PubMed ID: 20714351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of peripheral tolerance and immune regulation mediated by Treg.
    Sakaguchi S; Wing K; Yamaguchi T
    Eur J Immunol; 2009 Sep; 39(9):2331-6. PubMed ID: 19662638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foxp3+ regulatory T cells impede the priming of protective CD8+ T cells.
    Ertelt JM; Rowe JH; Mysz MA; Singh C; Roychowdhury M; Aguilera MN; Way SS
    J Immunol; 2011 Sep; 187(5):2569-77. PubMed ID: 21810602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion and activation of CD4(+)CD25(+) regulatory T cells in Heligmosomoides polygyrus infection.
    Finney CA; Taylor MD; Wilson MS; Maizels RM
    Eur J Immunol; 2007 Jul; 37(7):1874-86. PubMed ID: 17563918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B7-1/B7-2 blockade overrides the activation of protective CD8 T cells stimulated in the absence of Foxp3+ regulatory T cells.
    Ertelt JM; Buyukbasaran EZ; Jiang TT; Rowe JH; Xin L; Way SS
    J Leukoc Biol; 2013 Aug; 94(2):367-76. PubMed ID: 23744647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice.
    Serr I; Fürst RW; Achenbach P; Scherm MG; Gökmen F; Haupt F; Sedlmeier EM; Knopff A; Shultz L; Willis RA; Ziegler AG; Daniel C
    Nat Commun; 2016 Mar; 7():10991. PubMed ID: 26975663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Foxp3(+) T cells expressing RORγt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation.
    Yang BH; Hagemann S; Mamareli P; Lauer U; Hoffmann U; Beckstette M; Föhse L; Prinz I; Pezoldt J; Suerbaum S; Sparwasser T; Hamann A; Floess S; Huehn J; Lochner M
    Mucosal Immunol; 2016 Mar; 9(2):444-57. PubMed ID: 26307665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T-Cell (Treg) hybridoma as a novel tool to study Foxp3 regulation and Treg fate.
    Sharma R; Sung SS; Ju CY; Deshmukh US; Fu SM; Ju ST
    J Autoimmun; 2011 Sep; 37(2):113-21. PubMed ID: 21621978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory T cells control the dynamic and site-specific polarization of total CD4 T cells following Salmonella infection.
    Clay SL; Bravo-Blas A; Wall DM; MacLeod MKL; Milling SWF
    Mucosal Immunol; 2020 Nov; 13(6):946-957. PubMed ID: 32457450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foxp3(+) regulatory T cells, immune stimulation and host defence against infection.
    Rowe JH; Ertelt JM; Way SS
    Immunology; 2012 May; 136(1):1-10. PubMed ID: 22211994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic T-lymphocyte antigen 4 blockade augments the T-cell response primed by attenuated Listeria monocytogenes resulting in more rapid clearance of virulent bacterial challenge.
    Rowe JH; Johanns TM; Ertelt JM; Lai JC; Way SS
    Immunology; 2009 Sep; 128(1 Suppl):e471-8. PubMed ID: 19191906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treg and CTLA-4: two intertwining pathways to immune tolerance.
    Walker LS
    J Autoimmun; 2013 Sep; 45(100):49-57. PubMed ID: 23849743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis.
    Flores-Borja F; Jury EC; Mauri C; Ehrenstein MR
    Proc Natl Acad Sci U S A; 2008 Dec; 105(49):19396-401. PubMed ID: 19036923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation.
    Onishi Y; Fehervari Z; Yamaguchi T; Sakaguchi S
    Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10113-8. PubMed ID: 18635688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune quiescence in the oral mucosa is maintained by a uniquely large population of highly activated Foxp3
    Park JY; Chung H; DiPalma DT; Tai X; Park JH
    Mucosal Immunol; 2018 Jul; 11(4):1092-1102. PubMed ID: 29743613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
    Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
    J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficient SOCS3 expression in CD4+CD25+FoxP3+ regulatory T cells and SOCS3-mediated suppression of Treg function.
    Pillemer BB; Xu H; Oriss TB; Qi Z; Ray A
    Eur J Immunol; 2007 Aug; 37(8):2082-9. PubMed ID: 17621372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo expansion of CD4+Foxp3+ regulatory T cells mediated by GITR molecules.
    Nishioka T; Nishida E; Iida R; Morita A; Shimizu J
    Immunol Lett; 2008 Dec; 121(2):97-104. PubMed ID: 18930767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressive IL-17A
    Downs-Canner S; Berkey S; Delgoffe GM; Edwards RP; Curiel T; Odunsi K; Bartlett DL; Obermajer N
    Nat Commun; 2017 Mar; 8():14649. PubMed ID: 28290453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.